Galena Biopharma to Present at the 7th Annual Bio-Europe International Partnering Conference

Galena Biopharma to Present at the 7th Annual Bio-Europe International
Partnering Conference

LAKE OSWEGO, Ore., March 4, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma
(Nasdaq:GALE), a biotechnology company focused on developing innovative,
targeted oncology treatments addressing major unmet medical needs to advance
cancer care, today announced that Mark W. Schwartz, Ph.D., Executive Vice
President and Chief Executive Officer will present a corporate update at the
7^th Annual Bio-Europe International Partnering Conference. The presentation
will take place on Tuesday, March 12, 2013 at 9:15 AM local time at the Centre
Convencions Internacional Barcelona in Barcelona, Spain.

About Galena Biopharma

Galena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based
biopharmaceutical company that develops innovative, targeted oncology
treatments that address major unmet medical needs to advance cancer care. For
more information please visit us at www.galenabiopharma.com.

The Galena Biopharma, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=10647

CONTACT: Madeline Hatton
         Toll free: +1 (855) 855-GALE (4253), ext. 109
         info@galenabiopharma.com

         or

         Remy Bernarda
         IR Sense, LLC
         +1 (503) 400-6995
         remy@irsense.com

Galena Biopharma, Inc.
 
Press spacebar to pause and continue. Press esc to stop.